PDGFB rearrangement in dermatofibrosarcoma protuberans: Correlation with clinicopathologic characteristics and clinical implications

Human Pathology

Volumn 44, Issue 7, 2013, Pages 1300-1309

  Ha, Sang Yun ^a   Lee, Seung Eun ^a   Kwon, Mi Jung ^b   Kim, Yu Jin ^c   Lee, Eun Hee ^a   Seo, Jinwon ^b   Jang, Kee Taek ^a   Lee, Jeeyun ^a   Choi, Yoon La ^a,c  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Hallym University College of Medicine   (South Korea)

^c Samsung Medical Center   (South Korea)

Author keywords

CD34; Dermatofibrosarcoma protuberans; Imatinib; PDGFB

Indexed keywords

IMATINIB; PLATELET DERIVED GROWTH FACTOR B;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SIZE; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOFIBROSARCOMA PROTUBERANS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DOSAGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; WIDE EXCISION;

ADOLESCENT; ADULT; AGED; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 22; COLLAGEN TYPE I; DERMATOFIBROSARCOMA; FEMALE; GENE DOSAGE; GENE FUSION; GENE REARRANGEMENT; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; MITOSIS; NEOPLASM RECURRENCE, LOCAL; PROTO-ONCOGENE PROTEINS C-SIS; SKIN NEOPLASMS; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84879196344     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.09.021     Document Type: Article

References (31)

1. G. McArthur Dermatofibrosarcoma protuberans: recent clinical progress Ann Surg Oncol 14 2007 2876 2886
2. A.A. Sandberg, and J.A. Bridge Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Dermatofibrosarcoma protuberans and giant cell fibroblastoma Cancer Genet Cytogenet 140 2003 1 12
3. S.W. Weiss, and J.R. Goldblum Enzinger and Weiss's soft tissue tumors 5th ed 2007 Elsevier Philadelphia, PA
4. J.J. Abbott, A.M. Oliveira, and A.G. Nascimento The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans Am J Surg Pathol 30 2006 436 443
5. W.B. Bowne, C.R. Antonescu, and D.H. Leung Dermatofibrosarcoma protuberans: a clinicopathologic analysis of patients treated and followed at a single institution Cancer 88 2000 2711 2720
6. J.H. Connelly, and H.L. Evans Dermatofibrosarcoma protuberans: a clinicopathologic review with emphasis on fibrosarcomatous areas Am J Surg Pathol 16 1992 921 925
7. J.R. Goldblum, J.D. Reith, and S.W. Weiss Sarcomas arising in dermatofibrosarcoma protuberans: a reappraisal of biologic behavior in eighteen cases treated by wide local excision with extended clinical follow up Am J Surg Pathol 24 2000 1125 1130
8. T. Mentzel, A. Beham, D. Katenkamp, A.P. Dei Tos, and C.D. Fletcher Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance Am J Surg Pathol 22 1998 576 587
9. G.A. McArthur, G.D. Demetri, and A. van Oosterom Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225 J Clin Oncol 23 2005 866 873
10. P. Rutkowski, M. Debiec-Rychter, and Z. Nowecki Treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without csurgical resection J Eur Acad Dermatol Venereol 25 2011 264 270
11. P. Rutkowski, M. Van Glabbeke, and C.J. Rankin Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two Phase II clinical trials J Clin Oncol 28 2010 1772 1779
12. P. Rutkowski, A. Wozniak, and T. Switaj Advances in molecular characterization and targeted therapy in dermatofibrosarcoma protuberans Sarcoma 2011 2011 959132
13. S. Stacchiotti, F. Pedeutour, and T. Negri Dermatofibrosarcoma protuberans-derived fibrosarcoma: clinical history, biological profile and sensitivity to imatinib Int J Cancer 129 2011 1761 1772
14. H. Voth, J. Landsberg, and T. Hinz Management of dermatofibrosarcoma protuberans with fibrosarcomatous transformation: an evidence-based review of the literature J Eur Acad Dermatol Venereol 25 2011 1385 1391
15. J.J. Abbott, M. Erickson-Johnson, X. Wang, A.G. Nascimento, and A.M. Oliveira Gains of COL1A1-PDGFB genomic copies occur in fibrosarcomatous transformation of dermatofibrosarcoma protuberans Mod Pathol 19 2006 1512 1518
16. R. Craver, T. Dewenter, N. Ebran, and F. Pedeutour COL1A1-PDGFB fusion in a pediatric Bednar tumor with 2 copies of a der(22)t(17;22) Cancer Genet Cytogenet 168 2006 155 157
17. B. Llombart, C. Monteagudo, and O. Sanmartin Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors J Am Acad Dermatol 65 2011 564 575
18. B. Llombart, O. Sanmartin, and J.A. Lopez-Guerrero Dermatofibrosarcoma protuberans: clinical, pathological, and genetic (COL1A1-PDGFB) study with therapeutic implications Histopathology 54 2009 860 872
19. R.S. Macarenco, R. Zamolyi, and M.F. Franco Genomic gains of COL1A1-PDFGB occur in the histologic evolution of giant cell fibroblastoma into dermatofibrosarcoma protuberans Genes Chromosomes Cancer 47 2008 260 265
20. G. Maire, S. Fraitag, and L. Galmiche A clinical, histologic, and molecular study of 9 cases of congenital dermatofibrosarcoma protuberans Arch Dermatol 143 2007 203 210
21. K.U. Patel, S.S. Szabo, and V.S. Hernandez Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays Hum Pathol 39 2008 184 193
22. R. Salgado, B. Llombart, and R.M. Pujol Molecular diagnosis of dermatofibrosarcoma protuberans: a comparison between reverse transcriptase-polymerase chain reaction and fluorescence in situ hybridization methodologies Genes Chromosomes Cancer 50 2011 510 517
23. S. Segura, R. Salgado, and A. Toll Identification of t(17;22)(q22;q13) (COL1A1/PDGFB) in dermatofibrosarcoma protuberans by fluorescence in situ hybridization in paraffin-embedded tissue microarrays Hum Pathol 42 2011 176 184
24. T. Takahira, Y. Oda, and S. Tamiya Detection of COL1A1-PDGFB fusion transcripts and PDGFB/PDGFRB mRNA expression in dermatofibrosarcoma protuberans Mod Pathol 20 2007 668 675
25. D. Giacchero, G. Maire, and P.A. Nuin No correlation between the molecular subtype of COL1A1-PDGFB fusion gene and the clinico-histopathological features of dermatofibrosarcoma protuberans J Invest Dermatol 130 2010 904 907
26. L. Bianchini, G. Maire, and B. Guillot Complex t(5;8) involving the CSPG2 and PTK2B genes in a case of dermatofibrosarcoma protuberans without the COL1A1-PDGFB fusion Virchows Arch 452 2008 689 696
27. J. OÊDowd, and P. Laidler Progression of dermatofibrosarcoma protuberans to malignant fibrous histiocytoma: report of a case with implications for tumor histogenesis Hum Pathol 19 1988 368 370
28. M.G. Swaby, H.L. Evans, and C.D. Fletcher Dermatofibrosarcoma protuberans with unusual sarcomatous transformation: a series of 4 cases with molecular confirmation Am J Dermatopathol 33 2011 354 360
29. Z. Szollosi, B. Scholtz, K. Egervari, and Z. Nemes Transformed dermatofibrosarcoma protuberans: real time polymerase chain reaction detection of COL1A1-PDGFB fusion transcripts in sarcomatous areas J Clin Pathol 60 2007 190 194
30. M. Hisaoka, S. Okamoto, Y. Morimitsu, S. Tsuji, and H. Hashimoto Dermatofibrosarcoma protuberans with fibrosarcomatous areas: molecular abnormalities of the p53 pathway in fibrosarcomatous transformation of dermatofibrosarcoma protuberans Virchows Arch 433 1998 323 329
31. T. Takahira, Y. Oda, and S. Tamiya Microsatellite instability and p53 mutation associated with tumor progression in dermatofibrosarcoma protuberans Hum Pathol 35 2004 240 245